Diagnosis of Heart Failure With Preserved Ejection Fraction Among Patients With Unexplained Dyspnea-Reference-Cited by-同舟云学术

Diagnosis of Heart Failure With Preserved Ejection Fraction Among Patients With Unexplained Dyspnea

Published:2022-09-01 Issue:9 Volume:7 Page:891
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Reddy Yogesh N. V.¹,Kaye David M.²,Handoko M. Louis³,van de Bovenkamp Arno A.³,Tedford Ryan J.⁴,Keck Carson⁴,Andersen Mads J.⁵,Sharma Kavita⁶,Trivedi Rishi K.⁶,Carter Rickey E.⁷,Obokata Masaru⁸,Verbrugge Frederik H.¹⁹¹⁰,Redfield Margaret M.¹,Borlaug Barry A.¹

Affiliation:

1. Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota

2. Department of Cardiology, Alfred Hospital, Melbourne, Victoria, Australia

3. Department of Cardiology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands

4. Division of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston

5. Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark

6. Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland

7. Department of Health Sciences Research, Mayo Clinic, Jacksonville, Florida

8. Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan

9. Biomedical Research Institute, Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium

10. Centre for Cardiovascular Diseases, University Hospital Brussels, Jette, Belgium

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Link

https://jamanetwork.com/journals/jamacardiology/articlepdf/2793877/jamacardiology_reddy_2022_oi_220033_1663082225.68185.pdf

Reference34 articles.

1. Association of undifferentiated dyspnea in late life with cardiovascular and noncardiovascular dysfunction: a cross-sectional analysis from the ARIC study.;Ramalho;JAMA Netw Open,2019

2. Empagliflozin in heart failure with a preserved ejection fraction.;Anker;N Engl J Med,2021

3. The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial.;Nassif;Nat Med,2021

4. Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction.;Solomon;N Engl J Med,2019

5. Heart failure with preserved ejection fraction.;Redfield;N Engl J Med,2017

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. H2FPEF and HFA-PEFF scores performance and the additional value of cardiac structure and function in patients with atrial fibrillation;International Journal of Cardiology;2024-10

2. Definition, classification and diagnosis of pulmonary hypertension;European Respiratory Journal;2024-08-29

3. Heart failure risk assessment in patients with hypertrophic cardiomyopathy based on the H₂FPEF score;European Journal of Heart Failure;2024-08-27

4. Systematic review and meta‐analysis to predict mortality in heart failure with preserved ejection fraction: Development and validation of the HF‐DANAS score;ESC Heart Failure;2024-08-08

5. Clinical Significance of Exercise Pulmonary Hypertension With a Negative Diastolic Stress Test for Suspected Heart Failure With Preserved Ejection Fraction;Journal of the American Heart Association;2024-08-06